[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Timms et al., 1977 - Google Patents

Cell‐mediated immune response of chickens to Newcastle disease vaccines

Timms et al., 1977

View PDF
Document ID
12947292869416494181
Author
Timms L
Alexander D
Publication year
Publication venue
Avian pathology

External Links

Snippet

The leukocyte migration inhibition (LMI) test was used to demonstrate cell‐mediated immunity (CMI) and its relationship to immunoglobulin production, as assessed by the haemagglutination inhibition (HI) test, in chickens vaccinated with various Newcastle …
Continue reading at www.tandfonline.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Timms et al. Cell‐mediated immune response of chickens to Newcastle disease vaccines
DE3486293T4 (en) Vaccine preparation.
Ristic Anaplasmosis
Alexander Newcastle disease diagnosis
Davies Characteristics of a virus causing a pox disease in sheep and goats in Kenya, with observations on the epidemiology and control
Butterworth et al. Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control
Pope Pathology of lymphoid organs with emphasis on immunosuppression
MUMFORD et al. Virus and its relationship to the “poor performance” syndrome
Cambridge et al. Cell-mediated immune response to influenza virus infections in mice
Haesebrouck et al. Effect of intratracheal challenge of fattening pigs previously immunised with an inactivated influenza H1N1 vaccine
Bülow Further characterisation of the CVI 988 strain of Marek's disease virus
Davies et al. A new bluetongue virus serotype isolated in Kenya
Nagy et al. Vaccination of 1-day-old chicks with fowlpox virus by the aerosol, drinking water, or cutaneous routes
Hennessy et al. Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule
Timms et al. Cell mediated and humoral immune response of chickens to live infectious bronchitis vaccines
Krakowka et al. Influence of transplacentally acquired antibody on neonatal susceptibility to canine distemper virus in gnotobiotic dogs
Della-Porta et al. Bovine ephemeral fever virus
Burnet The growth of viruses on the chorioallantois of the chick embryo
MacOwan et al. Cloacal infection with Mycoplasma gallisepticum and the effect of inoculation with H120 infectious bronchitis vaccine virus
Araj et al. The host response in secondary hydatidosis of mice: II. Cell mediated immunity
Yachida et al. Relationship between several criteria of challenge‐immunity and humoral immunity in chickens vaccinated with avian infectious bronchitis vaccines
Bankowski et al. Tissue-culture systems with Newcastle disease virus and relationship of antigenicity to immunogenicity among strains
Gazdzinski et al. The agar‐gel precipitin response to the H120 and H52 vaccines of infectious bronchitis virus
Odeón et al. The role of cell-mediated immunity in the pathogenesis of bluetongue virus serotype 11 in the experimental infection of vaccine/sensitized calves
Ahmed et al. Response of pigeons to eight strains of Newcastle disease virus